Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.

Gnant MF, Berger AC, Huang J, Puhlmann M, Wu PC, Merino MJ, Bartlett DL, Alexander HR Jr, Libutti SK.

Cancer Res. 1999 Sep 15;59(18):4668-74.

2.

Endothelial monocyte activating polypeptide II (EMAP II) enhances the effect of TNF on tumor-associated vasculature.

Kayton ML, Libutti SK.

Curr Opin Investig Drugs. 2001 Jan;2(1):136-8. Review.

PMID:
11527006
3.

Involvement of endothelial monocyte activating polypeptide II in tumor necrosis factor-alpha-based anti-cancer therapy.

Lans TE, Van Horssen R, Eggermont AM, Ten Hagen TL.

Anticancer Res. 2004 Jul-Aug;24(4):2243-8. Review.

4.

In situ cytokine gene transfection using vaccinia virus vectors.

Lattime EC, Lee SS, Eisenlohr LC, Mastrangelo MJ.

Semin Oncol. 1996 Feb;23(1):88-100. Review.

PMID:
8607035
5.

Rationale for using TNF alpha and chemotherapy in regional therapy of melanoma.

Lejeune F, Liénard D, Eggermont A, Schraffordt Koops H, Rosenkaimer F, Gérain J, Klaase J, Kroon B, Vanderveken J, Schmitz P.

J Cell Biochem. 1994 Sep;56(1):52-61. Review.

PMID:
7806592
6.

The role of cytokines in osteoarthritis pathophysiology.

Fernandes JC, Martel-Pelletier J, Pelletier JP.

Biorheology. 2002;39(1-2):237-46. Review.

PMID:
12082286
7.

Endothelial-monocyte-activating polypeptide II.

Tas MP, Murray JC.

Int J Biochem Cell Biol. 1996 Aug;28(8):837-41. Review.

PMID:
8811833
8.

Cytokine-based gene therapy of human tumors. An overview.

Parmiani G, Arienti F, Sulé-Suso J, Melani C, Colombo MP, Ramakrishna V, Belli F, Mascheroni L, Rivoltini L, Cascinelli N.

Folia Biol (Praha). 1996;42(6):305-9. Review.

PMID:
9158940
9.
10.

[Tumor necrosis factor: pleiotropic cytokine].

Chouaib S, Robinet E, Zyad A, Branellec D.

Bull Cancer. 1992;79(10):935-49. Review. French.

PMID:
1292760
11.

Cytokine gene transfer in tumor cells as an approach to antitumor therapy.

Colombo MP, Mattei S, Parmiani G.

Int J Clin Lab Res. 1992;21(4):278-82. Review.

PMID:
1591380
12.

Electroporation gene therapy preclinical and clinical trials for melanoma.

Heller LC, Heller R.

Curr Gene Ther. 2010 Aug;10(4):312-7. Review.

PMID:
20557286
13.

Inhibition of and sensitization to the lethal effects of tumor necrosis factor.

Brouckaert P, Libert C, Cauwels A, Everaerdt B, Van Molle W, Ameloot P, Gansemans Y, Grijalba B, Takahashi N, Truong MJ, Van Leuven P, Fiers W.

J Inflamm. 1995-1996;47(1-2):18-26. Review.

PMID:
8913926
14.

[TNF: antitumoral agent at the border lines of immunity and inflammation].

Branellec D, Chouaib S.

Pathol Biol (Paris). 1991 Mar;39(3):230-9. Review. French.

PMID:
1646993
15.

Immunological gene therapy approaches for malignant melanoma. 2. Preclinical studies and clinical strategies.

Bonnekoh B, Bickenbach JR, Roop DR.

Skin Pharmacol. 1997;10(3):105-25. Review.

PMID:
9287392
16.

[Tumor necrosis factor: a cytokine with multiple actions].

Mencoboni M, Lerza R, Bogliolo G.

Recenti Prog Med. 1992 Jan;83(1):15-7. Review. Italian.

PMID:
1561477
17.

Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis.

Ortiz A, Bustos C, Alonso J, Alcázar R, López-Armada MJ, Plaza JJ, González E, Egido J.

Adv Nephrol Necker Hosp. 1995;24:53-77. Review.

PMID:
7572422
18.

Gene therapy of cancer.

Rosenberg SA.

Important Adv Oncol. 1992:17-38. Review. No abstract available.

PMID:
1582673
19.

Endothelial-monocyte activating polypeptides (EMAPs): tumor derived mediators which activate the host inflammatory response.

Kao J, Fan YG, Haehnel I, Clauss M, Stern D.

Behring Inst Mitt. 1993 Aug;(92):92-106. Review. No abstract available.

PMID:
8250820
20.

Possible relationships between in vivo antitumour activity and toxicity of tumour necrosis factor-alpha.

Palladino MA Jr, Patton JS, Figari IS, Shalaby MR.

Ciba Found Symp. 1987;131:21-38. Review.

PMID:
3330012

Supplemental Content

Support Center